Back to
Deutsche Bank AG
SMMT
Showing 0 of 5 quarters
Position history for
Deutsche Bank AG's holdings in Summit Therapeutics Inc.
No. Deutsche Bank exited its SMMT (Summit Therapeutics) position in Q1 2020. Its Q4 2019 13F listed 1,961 shares worth $3,000. Deutsche Bank first reported SMMT in Q1 2019 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.